These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 17891453

  • 1. Trichostatin A and 5 Aza-2' deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR.
    Pryzbylkowski P, Obajimi O, Keen JC.
    Breast Cancer Res Treat; 2008 Sep; 111(1):15-25. PubMed ID: 17891453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells.
    Yang X, Phillips DL, Ferguson AT, Nelson WG, Herman JG, Davidson NE.
    Cancer Res; 2001 Oct 01; 61(19):7025-9. PubMed ID: 11585728
    [Abstract] [Full Text] [Related]

  • 5. The RNA-binding protein HuR regulates GATA3 mRNA stability in human breast cancer cell lines.
    Licata LA, Hostetter CL, Crismale J, Sheth A, Keen JC.
    Breast Cancer Res Treat; 2010 Jul 01; 122(1):55-63. PubMed ID: 19728080
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
    Liu Z, Marquez M, Nilsson S, Holmberg AR.
    Oncol Rep; 2008 Jul 01; 20(1):151-4. PubMed ID: 18575731
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells.
    Zeng L, Jarrett C, Brown K, Gillespie KM, Holly JM, Perks CM.
    Exp Cell Res; 2013 Aug 15; 319(14):2282-95. PubMed ID: 23810988
    [Abstract] [Full Text] [Related]

  • 11. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
    Banwell CM, MacCartney DP, Guy M, Miles AE, Uskokovic MR, Mansi J, Stewart PM, O'Neill LP, Turner BM, Colston KW, Campbell MJ.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2004-13. PubMed ID: 16609009
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.
    Yang X, Ferguson AT, Nass SJ, Phillips DL, Butash KA, Wang SM, Herman JG, Davidson NE.
    Cancer Res; 2000 Dec 15; 60(24):6890-4. PubMed ID: 11156387
    [Abstract] [Full Text] [Related]

  • 13. Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.
    Sharma D, Saxena NK, Davidson NE, Vertino PM.
    Cancer Res; 2006 Jun 15; 66(12):6370-8. PubMed ID: 16778215
    [Abstract] [Full Text] [Related]

  • 14. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
    Liu J, Sidell N.
    Breast Cancer Res Treat; 2005 Nov 15; 94(2):161-9. PubMed ID: 16261415
    [Abstract] [Full Text] [Related]

  • 15. Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells.
    Bovenzi V, Momparler RL.
    Cancer Chemother Pharmacol; 2001 Jul 15; 48(1):71-6. PubMed ID: 11488527
    [Abstract] [Full Text] [Related]

  • 16. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
    Woodfield GW, Hitchler MJ, Chen Y, Domann FE, Weigel RJ.
    Clin Cancer Res; 2009 Jun 01; 15(11):3672-9. PubMed ID: 19458056
    [Abstract] [Full Text] [Related]

  • 17. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
    Lin FY, Chen YH, Lin YW, Tsai JS, Chen JW, Wang HJ, Chen YL, Li CY, Lin SJ.
    Arterioscler Thromb Vasc Biol; 2006 Dec 01; 26(12):2622-9. PubMed ID: 16990552
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO, Chen HJ, Tian H, Edenberg HJ.
    Alcohol Clin Exp Res; 2006 Jun 01; 30(6):928-37. PubMed ID: 16737450
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
    To SQ, Takagi K, Miki Y, Suzuki K, Abe E, Yang Y, Sasano H, Simpson ER, Knower KC, Clyne CD.
    J Steroid Biochem Mol Biol; 2012 Nov 01; 132(3-5):331-8. PubMed ID: 22929011
    [Abstract] [Full Text] [Related]

  • 20. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC.
    Prostate; 2008 Feb 01; 68(2):210-22. PubMed ID: 18092350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.